Scoliosis Market Size & Outlook, 2025-2033

Scoliosis Market Size

The global scoliosis market size was valued at USD 532.14 million in 2024, and it is projected to reach from USD 552.9 million in 2025 to USD 750.87 million by 2033, growing at a CAGR of 3.9% during the forecast period (2025–2033).

The global scoliosis market is primarily boosted by the surging prevalence of the disorder worldwide, owing to its enhanced diagnosis of the disease. In addition, the surge in the geriatric population is further increasing the burden of this disorder, which is anticipated to expedite the market expansion. Moreover, the significant market players are introducing advanced and innovative diagnosis and treatment alternatives for scoliosis, which is estimated to create opportunities for market expansion.

Scoliosis is a medical condition distinguished by an abnormal sideways curvature of the spine. While a slight curvature is normal, scoliosis involves a more pronounced and often S- or C-shaped curve. It typically develops during adolescence but can also occur in childhood or adulthood. The exact cause of scoliosis is not known, though it can be linked to factors such as genetics, neuromuscular conditions, or congenital spine abnormalities.

Symptoms of scoliosis may include irregular shoulders or hips, a visible curvature of the spine, and back pain. Treatment options vary Depending on the curvature's severity and the individual's age. Mild cases may require monitoring, while more severe cases necessitate bracing or surgery to correct the curvature and prevent further progression. Early detection through regular screenings is critical for effectively managing scoliosis and preventing potential complications.

To get more insights about this report Download Free Sample Report

Scoliosis Market Growth Factors

Increasing Prevalence of Scoliosis

The increasing prevalence of scoliosis is a significant driver for the scoliosis market. Epidemiological studies suggest that approximately 2-3% of adolescents worldwide are affected by this condition. Scoliosis can also manifest in adulthood, particularly in the form of degenerative scoliosis. Factors contributing to the rising prevalence include improved diagnostic capabilities leading to higher detection rates and demographic shifts such as an aging population.

For instance, as per a research article published in Frontiers, the prevalence of scoliosis screening positive among children and adolescents aged 17 in urban settings was 6.8%. Lifestyle factors and sedentary behaviors may also contribute to the development or exacerbation of scoliosis. As awareness about scoliosis increases, more individuals are screened and diagnosed at earlier stages, further amplifying the prevalence figures. This growing pool of diagnosed patients necessitates expanded treatment options, driving innovation and investment in the scoliosis market to cater to the needs of a larger patient population.

Growth in the Aging Population

The aging population is a crucial driver for the scoliosis market as degenerative forms of the condition become more prevalent with age. Individuals are more susceptible to spinal deformities such as degenerative scoliosis as they grow older. According to an article published in PubMed, Scoliosis affects over 8% of adults aged 25 and older, and this percentage increases to 68% in individuals over 60. Degenerative changes in the aging spine mostly cause the condition.

Moreover, as per the United Nations, the proportion of those aged 65 years and above is growing faster than those below 65. The global population aged 65 and older is expected to surge from 10% in 2022 to 16% in 2050. According to projections, the global population of individuals aged 65 years or older is expected to quadruple the number of children under five years old by 2050 and come close to matching the number of children under 12 years old. This demographic trend creates a larger pool of potential patients seeking treatment for scoliosis-related issues.

Market Challenges

Limited Awareness

Limited awareness about scoliosis, its symptoms, and available treatment options significantly restrain the scoliosis market growth. Many individuals, including patients, caregivers, and even healthcare professionals, may lack sufficient knowledge about the condition, leading to delays in diagnosis and therapy initiation. As scoliosis often develops gradually and may initially present with subtle symptoms, such as uneven shoulders or hips, it can go unnoticed or misinterpreted as a benign postural issue. Consequently, patients may need more timely medical attention, hindering the demand for scoliosis-related products and services. Such factors restrict the market growth.

Scoliosis Market Opportunities

Technological Advancements

The key market players are introducing technologically refined and efficient diagnosis and treatment options for scoliosis. For instance, in June 2023, ImageBiopsy Lab, a prominent company specializing in AI-driven medical imaging solutions, has recently introduced and obtained MDR CE certification for its latest software application, IB Lab SQUIRREL. This cutting-edge program provides a wide range of automated measurements for assessing and quantifying scoliosis, including coronal balance and Cobb angles, which are considered the orthopedic "Gold Standard" for assessing the disease.

Furthermore, in July 2023, Globus Medical, Inc., a prominent company specializing in musculoskeletal solutions, announced the official launch of the MARVEL™ Growing Rod System. This system is specifically designed for pediatric patients with early-onset scoliosis, allowing them to achieve and sustain correction while enabling growth through a minimally invasive distraction process. MARVEL™ growing rods have a robust geared mechanism that allows for dependable and effective lengthening within a wide expansion range of 40mm or 60mm. These rods also utilize PEEK polymer-bearing surfaces to limit the occurrence of wear. This is estimated to create opportunities for market growth.

Regional Insights

The global scoliosis market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant global scoliosis market shareholder and is expected to expand substantially during the forecast period. In North America, several factors contribute to the growth of the scoliosis market. The increasing prevalence of scoliosis, particularly among adolescents, drives demand for diagnosis and treatment options. Based on the American Association of Neurology, scoliosis impacts around 2-3 percent of the population, which equates to an estimated six to nine million individuals in the United States. Moreover, an estimated 29,000 surgical procedures for scoliosis are conducted annually on adolescents in the United States. In the United States, scoliosis accounts for 20% of all occurrences of spine deformities and contributes to 1.2% of total hospital expenses each year.

Furthermore, the launch of new and advanced solutions for the treatment of disease is estimated to create opportunities for market expansion. For instance, in December 2023, Dr. Zeke Harkleroad, a renowned expert in spinal health and wellbeing, is delighted to introduce a groundbreaking device, SpineCor, that has revolutionized the lives of individuals afflicted with scoliosis. Likewise, the regulatory authorities in this region are also approving the launch of a novel device for scoliosis disease treatment.

For instance, in May 2023, the US Food and Drug Administration (FDA) approved Globus Medical's REFLECT Scoliosis Correction System. The REFLECT device is designed to cure progressive scoliosis in young kids and retain motion while keeping stability and allowing for future controlled growth. It is claimed to be the company's first humanitarian device. This device is specifically intended for patients who are still growing and have a condition called progressive idiopathic scoliosis. These patients require surgery to achieve and sustain correction of their curved spine. Consequently, all these factors are estimated to drive the regional market growth.

Europe: Fastest-Growing Region

The European scoliosis market is primarily influenced by the increasing incidence of bone mineral deficiencies, the expanding acceptance of technologically improved treatments, and the robust distribution network established by leading manufacturers. Scoliosis is a prevalent condition among children between 10 and 15. In the United Kingdom, the prevalence of scoliosis among children is approximately 3 to 4 cases per 1000 individuals.

Furthermore, technological advancements and the subsequent increase in clinical trials and R&D activities are driving the market's growth. For instance, a study released in January 2024 reported that nighttime bracing could be a viable substitute for full-time bracing in individuals with adolescent idiopathic scoliosis, based on findings from a clinical trial conducted in Sweden. The researchers assessed Cobb angles on X-rays in people who underwent a combination of physical exercise and the technique. They discovered that this intervention effectively halted the advancement of the spine curve.

Type Analysis

The global scoliosis market is divided into cast braces, rigid braces, and non-rigid dynamic braces. Casting braces are occasionally used to treat scoliosis, particularly in pediatric cases with moderate spinal curvature. These braces are custom-fitted and molded directly onto the patient's body, typically made from plaster or fiberglass. The purpose of casting braces is to gradually correct the curvature of the spine by applying continuous pressure on the protruding areas while allowing growth in unaffected regions. Unlike traditional braces, which are adjustable, casting braces are fixed and must be replaced as the patient grows.

Casting braces are usually worn for several months, during which time they immobilize the spine and encourage gradual correction. However, they may not be suitable for all individuals with scoliosis, and their effectiveness can vary depending on factors like severity and type of curvature. Despite their limitations, casting braces offer a non-surgical option for managing scoliosis in select cases, particularly in children and adolescents whose skeletons are still developing. Regular monitoring and follow-up assessments are crucial to ensure the brace's efficacy and make any necessary adjustments.

Group Analysis

The global scoliosis market is divided into children, teenagers, and adults. Adults suffering from scoliosis are segmented into three categories: adult scoliosis patients who were surgically treated like adolescents, adults who did not receive treatment during their teenage, and adults with a type of scoliosis called degenerative scoliosis. The increasing prevalence of degenerative scoliosis in adults aged 65 and older and the rising number of adults who did not receive scoliosis treatment in their teenage, especially in underdeveloped regions like Africa, are expected to drive the segmental growth.

List of key players in Scoliosis Market

1. Boston Orthotics & Prosthetics
2. Chaneco
3. Spinal Technology Inc.
4. Optec USA Inc
5. DJO LLC (Subsidiary of Colfax Corporation)
6. Ossur Corporate
7. TRULIFE
8. Aspen Medical
9. LA Brace Center
10. Beacon Prosthetics and Orthotics

To get more findings about this report Download Market Share

Recent Developments

• February 2024- Momentum Health Inc. announced that their groundbreaking mobile application, Momentum Spine, has obtained clearance from the U.S. Food and Drug Administration (FDA). This advanced AI application provides a method to measure postural asymmetries, such as scoliosis, without intrusive procedures or radiation exposure. It specifically addresses the ongoing difficulty in treating spine deformities.
• March 2024- OrthoPediatrics Corp., a company dedicated only to developing the field of pediatric orthopedics, introduced a novel RESPONSE™ Rib and Pelvic Fixation system. This system is designed to treat children who have early-onset scoliosis (EOS). This signifies the company's 71st orthopedic treatment system designed for young patients.